Efficacy of low molecular weight heparin (Fragmin®) for thromboprophylaxis in medical patients: A randomized double blind trial;UBER DIE WIRKSAMKEIT NIEDERMOLEKULAREN HEPARINS (FRAGMIN®) IN DER THROMBOEMBOLIEPROPHYLAXE BEI INTERNISTISCHEN PATIENTEN. EINE RANDOMISIERTE DOPPELBLINDSTUDIE

Medizinische Klinik

Volumn 83, Issue 7, 1988, Pages 241-245

  Poniewierski, M ^a   Barthels, M ^a   Kuhn, M ^a   Poliwoda, H ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DALTEPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOSIS PREVENTION;

CLINICAL TRIALS; DOUBLE-BLIND METHOD; ENGLISH ABSTRACT; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMAN; INTERNAL MEDICINE; RANDOM ALLOCATION; THROMBOEMBOLISM;

EID: 0023896625     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)